Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value: $676M (100.0% shares, 0.0% debt)

Holdings (22)

INGN INOGEN INC 50.1%
Value $338M Shares 3,549,320 Share Price $95.37 * Est. Cost/Share $17.78 Unrealized @ Report Date +601.5%
GKOS GLAUKOS CORP 7.0%
Value $47.44M Shares 605,266 Share Price $78.37 * Est. Cost/Share $30.48 Unrealized @ Report Date +119.1%
CABO CABLE ONE INC 6.5%
Value $44.16M Shares 45,000 Share Price $981.38 * Est. Cost/Share $833.27 Unrealized @ Report Date 0.0%
KIDS ORTHOPEDIATRICS CORP 4.3%
Value $28.95M Shares 654,549 Share Price $44.23 * Est. Cost/Share $18.69 Unrealized @ Report Date +103.5%
FOLD AMICUS THERAPEUTICS INC 3.8%
Value $25.4M Shares 1,867,870 Share Price $13.60 * Est. Cost/Share $14.29 Unrealized @ Report Date -14.5%
AKBA AKEBIA THERAPEUTICS INC 3.8%
Value $25.39M Shares 3,100,000 Share Price $8.19 * Est. Cost/Share $12.34 Unrealized @ Report Date -44.4%
— AERIE PHARMACEUTICALS INC 3.2%
Value $21.41M Shares 450,714 Share Price $47.50 Est. Cost/Share $60.85 Unrealized @ Report Date —
— SEASPINE HLDGS CORP 2.9%
Value $19.73M Shares 1,308,037 Share Price $15.08 Est. Cost/Share $12.38 Unrealized @ Report Date —
CRVS CORVUS PHARMACEUTICALS INC 2.6%
Value $17.77M Shares 4,420,516 Share Price $4.02 * Est. Cost/Share $13.03 Unrealized @ Report Date -67.6%
SIBN SI BONE INC 2.5%
Value $16.82M Shares 892,685 Share Price $18.84 * Est. Cost/Share $18.92 Unrealized @ Report Date +2.3%
— ENTASIS THERAPEUTICS HLDGS I 2.2%
Value $14.75M Shares 2,181,843 Share Price $6.76 Est. Cost/Share $10.88 Unrealized @ Report Date —
GLPG GALAPAGOS NV 1.7%
Value $11.48M Shares 97,481 Share Price $117.78 Est. Cost/Share $112.97 Unrealized @ Report Date —
— NABRIVA THERAPEUTICS PLC 1.7%
Value $11.48M Shares 4,703,720 Share Price $2.44 Est. Cost/Share $7.20 Unrealized @ Report Date —
INSP INSPIRE MED SYS INC 1.5%
Value $9.937M Shares 175,000 Share Price $56.78 * Est. Cost/Share $42.52 Unrealized @ Report Date +27.1%
— ACCELERON PHARMA INC 1.4%
Value $9.233M Shares 198,261 Share Price $46.57 Est. Cost/Share $27.65 Unrealized @ Report Date —
STIM NEURONETICS INC 1.2%
Value $8.006M Shares 525,000 Share Price $15.25 * Est. Cost/Share $30.40 Unrealized @ Report Date -45.6%
— MERUS N V 1.1%
Value $7.426M Shares 502,795 Share Price $14.77 Est. Cost/Share $7.99 Unrealized @ Report Date —
— BLUEPRINT MEDICINES CORP 0.8%
Value $5.409M Shares 67,567 Share Price $80.05 Est. Cost/Share $80.05 Unrealized @ Report Date —
— VERONA PHARMA PLC 0.7%
Value $4.815M Shares 740,740 Share Price $6.50 Est. Cost/Share $11.66 Unrealized @ Report Date —
CRNX CRINETICS PHARMACEUTICALS IN 0.5%
Value $3.073M Shares 135,009 Share Price $22.76 * Est. Cost/Share $29.69 Unrealized @ Report Date -17.2%
— DERMIRA INC 0.4%
Value $2.724M Shares 201,059 Share Price $13.55 Est. Cost/Share $30.14 Unrealized @ Report Date —
— UNUM THERAPEUTICS INC 0.3%
Value $2.078M Shares 473,441 Share Price $4.39 Est. Cost/Share $47.61 Unrealized @ Report Date —